RPRX logo

Royalty Pharma plc (RPRX) CAPEX

annual CAPEX:

$2.52B+$408.18M(+19.29%)
December 31, 2024

Summary

  • As of today (September 16, 2025), RPRX annual capital expenditures is $2.52 billion, with the most recent change of +$408.18 million (+19.29%) on December 31, 2024.
  • During the last 3 years, RPRX annual CAPEX has risen by +$332.20 million (+15.16%).
  • RPRX annual CAPEX is now at all-time high.

Performance

RPRX CAPEX Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherRPRXcash flow metrics

quarterly CAPEX:

$1.11M+$57.00K(+5.39%)
June 30, 2025

Summary

  • As of today (September 16, 2025), RPRX quarterly capital expenditures is $1.11 million, with the most recent change of +$57.00 thousand (+5.39%) on June 30, 2025.
  • Over the past year, RPRX quarterly CAPEX has dropped by -$745.51 million (-99.85%).
  • RPRX quarterly CAPEX is now -99.92% below its all-time high of $1.34 billion, reached on September 30, 2021.

Performance

RPRX quarterly CAPEX Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherRPRXcash flow metrics

TTM CAPEX:

$1.69B-$745.51M(-30.57%)
June 30, 2025

Summary

  • As of today (September 16, 2025), RPRX TTM capital expenditures is $1.69 billion, with the most recent change of -$745.51 million (-30.57%) on June 30, 2025.
  • Over the past year, RPRX TTM CAPEX has dropped by -$592.92 million (-25.94%).
  • RPRX TTM CAPEX is now -44.11% below its all-time high of $3.03 billion, reached on September 30, 2024.

Performance

RPRX TTM CAPEX Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherRPRXcash flow metrics

RPRX CAPEX Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+19.3%-99.8%-25.9%
3 y3 years+15.2%-99.4%+0.6%
5 y5 years+46.6%-99.8%+59.1%

RPRX CAPEX Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+43.2%-99.9%+5.4%-44.1%+22.3%
5 y5-yearat high+46.6%-99.9%+1210.6%-44.1%+59.1%
alltimeall timeat high>+9999.0%-99.9%+1210.6%-44.1%+176.5%

RPRX CAPEX History

DateAnnualQuarterlyTTM
Jun 2025
-
$1.11M(+5.4%)
$1.69B(-30.6%)
Mar 2025
-
$1.06M(-99.8%)
$2.44B(-3.4%)
Dec 2024
$2.52B(+19.3%)
$496.42M(-58.4%)
$2.52B(-16.7%)
Sep 2024
-
$1.19B(+60.0%)
$3.03B(+32.5%)
Jun 2024
-
$746.63M(+767.3%)
$2.29B(+42.9%)
Mar 2024
-
$86.08M(-91.4%)
$1.60B(-24.4%)
Dec 2023
$2.12B(+20.0%)
$1.00B(+122.2%)
$2.12B(+52.8%)
Sep 2023
-
$451.13M(+646.3%)
$1.38B(-38.5%)
Jun 2023
-
$60.45M(-90.0%)
$2.25B(-4.8%)
Mar 2023
-
$601.71M(+121.7%)
$2.36B(+34.1%)
Dec 2022
$1.76B(-19.6%)
$271.46M(-79.4%)
$1.76B(+6.0%)
Sep 2022
-
$1.32B(+652.1%)
$1.66B(-1.2%)
Jun 2022
-
$175.01M(>+9900.0%)
$1.68B(-0.3%)
Mar 2022
-
$85.00K(-100.0%)
$1.69B(-23.0%)
Dec 2021
$2.19B
$171.73M(-87.1%)
$2.19B(-22.4%)
DateAnnualQuarterlyTTM
Sep 2021
-
$1.34B(+639.5%)
$2.82B(+23.3%)
Jun 2021
-
$180.67M(-64.1%)
$2.29B(-11.4%)
Mar 2021
-
$503.07M(-37.5%)
$2.59B(+18.5%)
Dec 2020
$2.18B(+26.8%)
$805.16M(+0.3%)
$2.18B(+18.4%)
Sep 2020
-
$802.47M(+68.8%)
$1.84B(+73.3%)
Jun 2020
-
$475.33M(+378.7%)
$1.06B(+73.8%)
Mar 2020
-
$99.29M(-78.7%)
$612.31M(-64.4%)
Dec 2019
$1.72B(+538.5%)
$466.77M(+1948.4%)
$1.72B(+37.2%)
Sep 2019
-
$22.79M(-2.9%)
$1.25B(+1.8%)
Jun 2019
-
$23.46M(-98.1%)
$1.23B(+1.9%)
Mar 2019
-
$1.21B
$1.21B
Dec 2018
$269.59M(-88.2%)
-
-
Dec 2017
$2.29B(>+9900.0%)
-
-
Dec 2016
$0.00(0.0%)
-
-
Dec 2015
$0.00
-
-

FAQ

  • What is Royalty Pharma plc annual capital expenditures?
  • What is the all time high annual CAPEX for Royalty Pharma plc?
  • What is Royalty Pharma plc annual CAPEX year-on-year change?
  • What is Royalty Pharma plc quarterly capital expenditures?
  • What is the all time high quarterly CAPEX for Royalty Pharma plc?
  • What is Royalty Pharma plc quarterly CAPEX year-on-year change?
  • What is Royalty Pharma plc TTM capital expenditures?
  • What is the all time high TTM CAPEX for Royalty Pharma plc?
  • What is Royalty Pharma plc TTM CAPEX year-on-year change?

What is Royalty Pharma plc annual capital expenditures?

The current annual CAPEX of RPRX is $2.52B

What is the all time high annual CAPEX for Royalty Pharma plc?

Royalty Pharma plc all-time high annual capital expenditures is $2.52B

What is Royalty Pharma plc annual CAPEX year-on-year change?

Over the past year, RPRX annual capital expenditures has changed by +$408.18M (+19.29%)

What is Royalty Pharma plc quarterly capital expenditures?

The current quarterly CAPEX of RPRX is $1.11M

What is the all time high quarterly CAPEX for Royalty Pharma plc?

Royalty Pharma plc all-time high quarterly capital expenditures is $1.34B

What is Royalty Pharma plc quarterly CAPEX year-on-year change?

Over the past year, RPRX quarterly capital expenditures has changed by -$745.51M (-99.85%)

What is Royalty Pharma plc TTM capital expenditures?

The current TTM CAPEX of RPRX is $1.69B

What is the all time high TTM CAPEX for Royalty Pharma plc?

Royalty Pharma plc all-time high TTM capital expenditures is $3.03B

What is Royalty Pharma plc TTM CAPEX year-on-year change?

Over the past year, RPRX TTM capital expenditures has changed by -$592.92M (-25.94%)
On this page